Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0016 | 0.0762 | 0.0762 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0027 | 0.1873 | 0.1873 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.3982 | 0.2428 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.8546 | 0.8546 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.3982 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.2519 | 0.2519 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0071 | 0.6537 | 0.6252 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.3982 | 0.2428 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.6537 | 0.6537 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0016 | 0.0762 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0016 | 0.0762 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.3982 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.3982 | 0.2428 |
Brugia malayi | Cytochrome P450 family protein | 0.0027 | 0.1873 | 0.1203 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0016 | 0.0762 | 0.0762 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.3982 | 0.3486 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.3982 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.3982 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0033 | 0.2519 | 0.1902 |
Schistosoma mansoni | hypothetical protein | 0.0071 | 0.6537 | 0.6668 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.3982 | 0.3982 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0033 | 0.2519 | 0.1902 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.8546 | 0.8546 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0016 | 0.0762 | 0.0762 |
Leishmania major | cytochrome p450-like protein | 0.0016 | 0.0762 | 0.5 |
Schistosoma mansoni | eyes absent homolog | 0.009 | 0.8546 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0016 | 0.0762 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0104 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0104 | 1 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0033 | 0.2519 | 0.2519 |
Trypanosoma brucei | cytochrome P450, putative | 0.0016 | 0.0762 | 0.5 |
Brugia malayi | hypothetical protein | 0.009 | 0.8546 | 0.8426 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Inhibition of human recombinant MMP1 at 100 uM after 1 hr by fluorescence polarization based competition assay | ChEMBL. | 21719286 |
Inhibition (binding) | = 5 % | Inhibition of human peptide deformylase at 100 uM after 1 hr by fluorescence polarization based competition assay | ChEMBL. | 21719286 |
Inhibition (binding) | = 7 % | Inhibition of Escherichia coli peptide deformylase at 100 uM after 1 hr by fluorescence polarization based competition assay | ChEMBL. | 21719286 |
Inhibition (binding) | = 10 % | Inhibition of porcine kidney microsomal aminopeptidase N at 100 uM after 1 hr by fluorescence polarization based competition assay | ChEMBL. | 21719286 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.